"Hong Kong Stocks" Hang Seng Index rises 48 points in half a day, robot concept heats up

The Hong Kong Hang Seng Index rose 48 points in the first half of the day, reporting at 25,809 points. Market expectations for a Federal Reserve interest rate cut have increased, leading to a surge in robotics concept stocks. The FTSE China 50 Index has adjusted its constituent stocks, with CHINAHONGQIAO, CATL, and Hengrui Pharma being included. The United States is promoting the robotics industry, causing related concept stocks to rise. Mainland China has suspended or adjusted subsidies for replacing old cars with new ones, leading to declines in car stocks BYD and Nio. Other technology stocks showed mixed results, with Alibaba and Tencent slightly down, while Meituan and Bilibili saw increases

The Hang Seng Index opened 43 points higher, Hongqiao and CATL were included in the FTSE China Index, and Jingsheng Electronics entered the northbound trading｜Hong Kong stock market opens

The Hang Seng Index opened 43 points higher this morning, reporting at 25,804 points. FTSE Russell announced the inclusion of CHINAHONGQIAO, CATL, and Hengrui Pharma in the FTSE China 50 Index constituents, with stock prices rising by 2.8%, 0.3%, and remaining unchanged, respectively. U.S. stocks rose as the ADP job reduction raised expectations for a Federal Reserve rate cut, with all three major indices increasing. The Trump administration is promoting robotics technology, causing Tesla's stock price to surge over 4%. Joyson Electronics has been added to the Hong Kong Stock Connect eligible securities list, with its stock price rising by 1%

The Hang Seng Index closed up 0.13%, and the Hang Seng Tech Index rose 0.11%. Meituan increased by nearly 6%, Hengrui Pharma rose by nearly 5%, GDS surged over 3%, and JD.com rose over 2%

The Hang Seng Index rose 0.46% at midday, and the Hang Seng TECH Index rose 0.51%

36Kr learned that the Hang Seng Index rose 0.46% at midday, and the Hang Seng TECH Index rose 0.51%; the pharmaceutical and biotechnology, paper, and machinery sectors led the gains, with Hengrui Pharma rising over 5%, SANHUA rising over 4%, and ND PAPER rising over 2%; the media, software services, and coal sectors saw the largest declines, with Youjia Innovation falling over 8%, Kuaishou falling over 2%, and Yanzhou Coal Mining falling over 1%; southbound funds had a net purchase of HKD 602 million

Hengrui Pharma's SHR-1139 injection has been approved to conduct clinical trials

Hengrui Pharma announced that its subsidiary Guangdong Hengrui received a notification from the National Medical Products Administration, approving SHR-1139 injection to conduct clinical trials for pyoderma gangrenosum. To date, the cumulative R&D investment for the HR-1139 injection-related project is approximately 100 million RMB